News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Inimex Pharmaceuticals Inc. Announces Series A Venture Capital Financing



10/19/2005 5:08:58 PM

Inimex Pharmaceuticals today announced the first closing of a Series A Financing for US$4.5 million (C$6.0 million) led by a syndicate of venture capital funds: BDC Venture Capital, the Canadian Medical Discoveries Fund (CMDF) advised by MDS Capital, and the Working Opportunity Fund managed by GrowthWorks(TM) Capital. Proceeds of the financing will support the lead optimization and pre-clinical development of the first drug based on Inimex' novel innate immunity platform.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES